Vimarsana
Biggest News Aggregation in the World

Page 3 - Disease Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disease Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disease Analysis Today - Breaking & Trending Today

Pakistan bears highest burden of Hepatitis C in the World - Vimarsana News

Pakistan bears highest burden of Hepatitis C in the World

Liver cancer fastest growing type of cancer due to high prevalence rates of viral hepatitis, experts

Pakistan now home to world's highest number of hepatitis C patients - Vimarsana News

Pakistan now home to world's highest number of hepatitis C patients

Reuse of needles and syringes, unscreened blood transfusions, and sharing of surgical instruments driving increase in new cases

<i>The Lancet</i>: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries - Vimarsana News

<i>The Lancet</i>: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries

Peer-reviewed / Simulation or Modelling / People A new modelling study has estimated that from 2000 to 2030 vaccination against 10 major pathogens - including measles, rotavirus, HPV and hepatitis B - will have prevented 69 million deaths in low-income and middle-income countries (LMICs). The study estimated that, as a result of vaccination programmes, those born in 2019 will experience 72% lower mortality from the 10 diseases over their lifetime than if there was no immunisation. The greatest impact of vaccination was estimated to occur in children under five - mortality from the 10 diseases...

2020 Infectious Diseases Disease Analysis &#x2013; Seasonal Influenza Vaccines &#x2013; ResearchAndMarkets.com - Vimarsana News

2020 Infectious Diseases Disease Analysis &#x2013; Seasonal Influenza Vaccines &#x2013; ResearchAndMarkets.com

ResearchAndMarkets.com’s offering. The seasonal influenza vaccines market in the US, Japan, and five major European markets (France, Germany, Italy, Spain, and the UK) is expected to continue to expand over the next 10 years, largely due to the continued uptake of premium-priced vaccines in the elderly subgroup, including quadrivalent forms of Fluzone High-Dose (HD) and Fluad, as well as the launch of the first-in-class adjuvanted nanoparticle vaccine, NanoFlu. Further to this, an aging population in the US, Japan, five major European markets, and other developed countries will increase the...